Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: J Neuropathol Exp Neurol. 2012 Jan;71(1):83–89. doi: 10.1097/NEN.0b013e31823fe8f1

Table.

Concordance of RB1 Status as Determined by Fluorescence In Situ Hybridization and Immunohistochemistry Compared to The Cancer Genome Atlas

Tumor
ID
RB1 deletion
by FISH
Copy
number
(log2 ratio)a
RB1
protein
by IHCb, c
RB1
expression
(log2 ratio)d
RB1 somatic
mutatione
GBM
Subtypef
08-0520 Homozygous −2.406 0 −0.255 NA N
08-0350 Homozygous −2.146 0 −0.145 NA P
08-0386 Hemizygous −0.399 0 −0.33 NA N
08-0389 Hemizygous −0.682 0 0.093 Novel nonsense
mutation
NA
08-0349 Hemizygous −0.638 1 0.036 NA N
08-0359 Hemizygous −0.549 1 0.584 No P
08-0347 Hemizygous −0.473 1 0.544 No P
08-0511 Hemizygous −0.704 2 0.474 NA C
08-0517 Hemizygous −0.828 2 0.515 NA P
08-0516 Hemizygous −0.606 2 0.402 NA NA
08-0357 Hemizygous −0.571 2 0.735 NA C
08-0246 Not Del −0.322 1 0.835 No C
08-0512 Not Del −0.302 1 −0.7509 NA M
08-0360 Not Del −0.270 1 0.648 No M
08-0375 Not Del −0.050 1 0.691 No C
08-0380 Not Del −0.041 1 0.959 No
08-0518 Not Del −0.036 1 1.006 NA C
08-0356 Not Del −0.032 1 1.061 NA NA
08-0355 Not Del −0.016 1 1.016 NA C
08-0385 Not Del NA 1 0.532 No P
08-0345 NA −0.080 2 1.333 NA NA
08-0510 Not Del −0.132 2 1.108 NA M
08-0514 Not Del −0.088 2 1.063 NA C
08-0353 Not Del −0.083 2 1.158 No NA
08-0390 Not Del −0.003 2 1.148 No M
08-0522 Not Del 0.048 2 0.986 NA M
08-0392 Not Del −0.083 2 0.625 NA M
08-0531 Not Del −0.063 2 0.777 NA C
08-0244 Not Del −0.056 2 0.711 NA NA
08-0521 Not Del −0.004 2 0.591 NA NA
08-0358 Not Del −0.003 2 0.85 NA C
08-0344 Not Del 0.020 2 0.615 No P
08-0525 Not Del 0.041 2 1.399 NA NA
08-0381 Not Del NA 2 NA NA NA

CGH, comparative genomic hybridization; FISH, fluorescence in situ hybridization; GBM, glioblastoma; IHC, immunohistochemistry; NA, data not available; No Del, no deletion; RB1, Retinoblastoma Tumor Suppressor Protein; TCGA, The Cancer Genome Atlas.

a

Copy number [Tumor/Normal] data from TCGA, HMS.harvard HG-CGH-244A; gene deletion defined as [log2(Tumor/Normal) less than or equal to −0.4 (fold change of copy number in tumor vs. normal less than or equal to 0.758)] (11).

b

Mean IHC score for tumors with decreased RB1 copy number by array CGH was significantly different than the mean IHC score for tumors with intact RB1 (0.95 vs. 1.48, p<0.05; n=32).

c

The mean IHC score for tumors with loss of RB1 transcript expression was significantly different than the mean IHC score for tumors with intact RB1 expression (0 vs. 1.42, p<0.00005; n=33).

d

Expression [Tumor/Normal] data from TCGA, AgilentG4502A_07; loss of RB1 expression defined as [log2(Tumor/Normal) less than 0 (fold-change of expression in tumor vs. normal less than 1)].

e

Sequencing data from TCGA, hgsc.bcm.edu (11).

f

GBM subtype as determined by Verhaak et al (18). P, proneural; N, M, Mesenchymal; C, Classical